S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
'Knock at the Cabin' knocks off 'Avatar' at the box office
NASDAQ:BIVI

BioVie - BIVI Short Interest Ratio & Short Volume

$5.41
-0.28 (-4.92%)
(As of 02/3/2023 09:03 PM ET)
Add
Compare
Today's Range
$5.36
$5.77
50-Day Range
$4.65
$13.38
52-Week Range
$1.33
$14.38
Volume
124,300 shs
Average Volume
336,778 shs
Market Capitalization
$165.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

BioVie Short Interest Data

Current Short Volume
391,600 shares
Previous Short Volume
458,500 shares
Change Vs. Previous Month
-14.59%
Dollar Volume Sold Short
$2.15 million
Short Interest Ratio / Days to Cover
0.3
Last Record Date
January 15, 2023
Outstanding Shares
30,530,000 shares
Float Size
6,590,000 shares
Short Percent of Float
5.94%
Today's Trading Volume
124,300 shares
Average Trading Volume
336,778 shares
Today's Volume Vs. Average
-63.09%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling BioVie ?

Sign up to receive the latest short interest report for BioVie and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BIVI Short Interest Over Time

BIVI Days to Cover Over Time

BIVI Percentage of Float Shorted Over Time

BioVie (NASDAQ:BIVI) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/2023391,600 shares $2.15 million -14.6%5.9%0.3 $5.50
12/30/2022458,500 shares $3.56 million -25.2%6.5%0.4 $7.77
12/15/2022612,700 shares $7.81 million +61.5%8.7%0.6 $12.74
11/30/2022379,400 shares $2.56 million +68.0%5.4%0.6 $6.74
11/15/2022225,900 shares $1.12 million +34.5%3.2%0.5 $4.97
10/31/2022167,900 shares $710,217.00 +35.5%9.8%0.4 $4.23
10/15/2022123,900 shares $324,618.00 -11.1%7.3%0.3 $2.62
9/30/2022139,300 shares $346,857.00 -29.2%8.2%0.4 $2.49
9/15/2022196,800 shares $495,936.00 +198.6%14.1%0.6 $2.52
8/31/202265,900 shares $237,899.00 +20.7%4.5%0.2 $3.61
8/15/202254,600 shares $129,948.00 -21.4%3.7%1 $2.38
7/31/202269,500 shares $149,425.00 -11.2%1.4%1.3 $2.15
7/15/202278,300 shares $140,157.00 +19.2%1.5%1.6 $1.79
6/30/202265,700 shares $95,265.00 -10.0%1.3%1.4 $1.45
6/15/202273,000 shares $124,830.00 -6.7%1.4%1.4 $1.71
5/31/202278,200 shares $200,192.00 -35.7%1.5%1.9 $2.56
5/15/2022121,700 shares $318,854.00 -14.7%2.4%3.2 $2.62
4/30/2022142,700 shares $530,844.00 -2.5%2.8%3.2 $3.72
4/15/2022146,400 shares $647,088.00 +9.8%2.9%2.7 $4.42
3/31/2022133,400 shares $629,648.00 -20.9%2.6%2.5 $4.72
3/15/2022168,700 shares $474,047.00 +10.3%3.3%3.6 $2.81
2/28/2022152,900 shares $475,519.00 -4.0%3.0%3.3 $3.11
2/15/2022159,300 shares $505,777.50 -11.0%3.1%3 $3.18
1/31/2022178,900 shares $567,113.00 -5.0%3.5%3.2 $3.17
1/15/2022188,400 shares $842,148.00 -21.9%3.7%2.1 $4.47
12/31/2021241,100 shares $1.08 million -5.9%4.8%2.6 $4.50
12/15/2021256,100 shares $1.30 million +12.3%5.1%2.6 $5.07
11/30/2021228,000 shares $1.47 million -14.8%4.6%2.2 $6.44
11/15/2021267,600 shares $1.58 million +13.6%5.4%2.6 $5.89
10/29/2021235,600 shares $1.44 million -12.3%4.8%2.1 $6.12
10/15/2021268,500 shares $1.58 million -12.6%5.5%2.6 $5.90
9/30/2021307,300 shares $2.06 million +7.2%6.2%4.3 $6.69
9/15/2021286,600 shares $2.22 million +5.5%5.8%4.6 $7.76
8/31/2021271,600 shares $2.17 million +15.0%2.2%4.5 $7.98
8/13/2021236,200 shares $1.92 million +9.0%2.0%4.5 $8.13
7/30/2021216,800 shares $3.07 million -10.2%2.0%4.1 $14.14
7/15/2021241,300 shares $3.49 million -4.4%2.2%3.9 $14.48
6/30/2021252,300 shares $4.28 million +9.6%6.2%3.4 $16.95
6/15/2021230,300 shares $3.80 million +3.9%5.7%2.9 $16.50
5/28/2021221,700 shares $3.05 million -3.4%8.7%2.9 $13.75













BIVI Short Interest - Frequently Asked Questions

What is BioVie's current short interest?

Short interest is the volume of BioVie shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 391,600 shares of BIVI short. 5.94% of BioVie's shares are currently sold short. Learn More on BioVie's current short interest.

What is a good short interest percentage for BioVie?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.94% of BioVie's floating shares are currently sold short.

Is BioVie's short interest increasing or decreasing?

BioVie saw a decline in short interest during the month of January. As of January 15th, there was short interest totaling 391,600 shares, a decline of 14.6% from the previous total of 458,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is BioVie's float size?

BioVie currently has issued a total of 30,530,000 shares. Some of BioVie's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioVie currently has a public float of 6,590,000 shares.

How does BioVie's short interest compare to its competitors?

5.94% of BioVie's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BioVie: Liminal BioSciences Inc. (0.15%), Xeris Biopharma Holdings, Inc. (4.39%), GlycoMimetics, Inc. (1.56%), Chimerix, Inc. (3.57%), Spectrum Pharmaceuticals, Inc. (2.73%), InterCure Ltd. (0.26%), Merrimack Pharmaceuticals, Inc. (6.42%), Affimed (2.76%), Ovid Therapeutics Inc. (0.39%), and Nuvectis Pharma, Inc. (0.66%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), PG&E Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks.

What does it mean to sell short BioVie stock?

Short selling BIVI is an investing strategy that aims to generate trading profit from BioVie as its price is falling. BIVI shares are trading down $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioVie?

A short squeeze for BioVie occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIVI, which in turn drives the price of the stock up even further.

How often is BioVie's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIVI, twice per month. The most recent reporting period available is January, 15 2023.



This page (NASDAQ:BIVI) was last updated on 2/6/2023 by MarketBeat.com Staff